Welcome to LookChem.com Sign In|Join Free
  • or
Benzonitrile, 4-(4-morpholinyl)-3-(trifluoromethyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

677704-57-3

Post Buying Request

677704-57-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

677704-57-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 677704-57-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,7,7,0 and 4 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 677704-57:
(8*6)+(7*7)+(6*7)+(5*7)+(4*0)+(3*4)+(2*5)+(1*7)=203
203 % 10 = 3
So 677704-57-3 is a valid CAS Registry Number.

677704-57-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-morpholino-3-(trifluoromethyl)benzonitrile

1.2 Other means of identification

Product number -
Other names 4-(4-morpholinyl)-3-(trifluoromethyl)-benzonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:677704-57-3 SDS

677704-57-3Relevant academic research and scientific papers

OXADIAZINONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES

-

Page/Page column 173, (2020/08/22)

The present invention includes name compounds of general formula (I) in which R1, Y, and R3 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compos

THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY ON PROTEIN KINASES

-

Paragraph 0388-0390, (2013/03/26)

The present invention relates to a thieno[3,2-d]pyrimidine derivative of formula (I), or a pharmaceutically acceptable salt, hydrate or solvate thereof, which has an excellent inhibitory activity on protein kinases, and a pharmaceutical composition comprising the same is effective in preventing or treating abnormal cell growth diseases.

NOVEL BRONCHODILATING DIAZAHETEROARYLS

-

Page/Page column 34; 36, (2012/03/08)

The invention relates to novel compounds having the general formula (I), and which compounds are useful to treat a disorder or disease characterized by bronchoconstriction, e.g. COPD and asthma.

NOVEL OXADIAZOLE COMPOUNDS

-

Page/Page column 139-140, (2011/06/26)

Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or antagonists of the S1P family of G protein-coupled receptors for treating diseases associated with modulation o

THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY ON PROTEIN KINASES

-

Page/Page column 53; 54, (2011/08/21)

The present invention relates to a thieno[3,2-d]pyrimidine derivative of formula (I), or a pharmaceutically acceptable salt, hydrate or solvate thereof, which has an excellent inhibitory activity on protein kinases, and a pharmaceutical composition comprising the same is effective in preventing or treating abnormal cell growth diseases.

NOVEL BRONCHODILATING DIAZAHETEROARYLS

-

Page/Page column 81, (2010/09/17)

The invention relates to novel compounds having the general formula (I), and which compounds are useful to treat a disorder or disease characterized by bronchoconstriction, e.g. COPD and asthma.

OXADIAZOLE DIARYL COMPOUNDS

-

Page/Page column 59, (2009/05/29)

The invention relates to compounds of formula (I): wherein R1, R2, Ra , Rb,Rc and W, have the meanings given in claim 1. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.

OXADIAZOLE DERIVATIVES

-

Page/Page column 120, (2009/05/29)

The invention relates to compounds of formula (I): wherein R1, R2, Ra, Rb, W, Q and S have the meanings given in claim 1. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.

NOVEL OXADIAZOLE COMPOUNDS

-

Page/Page column 112, (2008/12/06)

Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or antagonists of the S1P family of G protein-coupled receptors for treating diseases associated with modulation o

NOVEL PYRIMIDINEAMIDE DERIVATIVES AND THE USE THEREOF

-

Page 31-32, (2008/06/13)

The invention relates to novel substituted N-(3-benzoylaminophenyl)-4-pyridyl-2-pyrimidinarnine derivatives, processes for the preparation thereof, pharmaceutical compositions containing same, the use thereof optionally in combination with one or more oth

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 677704-57-3